• Researchers Call for an Open AI Virtual Cell, Outline Challenges to Overcome

    Dec 18 | Bio-IT World | In a Perspectives paper published last week in Cell, researchers from Stanford University, Genentech, and the Chan-Zuckerberg Initiative issued a call for AI to build a virtual cell. Technology is ripe for a biologically-valuable virtual cell, they say, outlining their views of the priorities and opportunities. More

  • Renee Iacona on Why Future Scientists Need to Learn About Data Science

    Dec 17 | Bio-IT World | It has been a momentous year for artificial intelligence and machine learning. AI models can simulate clinical trials, diagnose diseases early, and detect biomarkers, and there is still no shortage of innovative ideas. However, there are some concerns surrounding AI/ML that have also been at the forefront of the industry. The latest episode of Trends from the Trenches covers one of these concerns. More

  • Ingredient in Children’s Glue Helps Tumors Retain Cancer Drug

    Dec 13 | Bio-IT World | Japan has long taken a leadership role in the pursuit of boron neutron capture therapy (BNCT) as a treatment for cancer. The approach involves injecting patients with a boron-containing compound that accumulates in tumor cells and acts as an exclusive target for neutrons to kill and was the research focus of a pair of Harvard scientists throughout the 1950s. More

  • Some Gut Bacteria Can be Transmitted Through Close Social Contact

    Dec 11 | Bio-IT World | An intriguing new study suggests that the people we interact with socially influence the bacteria populating our gut. The implication is that some diseases considered nontransmissible may have a component that makes them contagious. More

  • Russia Launches Comprehensive Study Genomes Of Living Organisms In Arctic Region

    Dec 10 | Bio-IT World | A project to study the genomes of living organisms in the Arctic region, known as “A Thousand Arctic Genomes,” has been launched in Russia. As part of the project, scientists will create genetic data banks and perform whole-genome sequencing of Arctic inhabitants in order to assess biodiversity and use the data obtained to preserve it. More

  • ‘Therapeutic EVs’ in a Nasal Spray Could One Day Treat Alzheimer’s Disease

    Dec 05 | Bio-IT World | It sounds too good to be true: a nasal spray that delays Alzheimer’s-related behavioral and cognitive problems a decade or more after initial diagnosis. But promising first steps in that direction have already been taken using “therapeutic EVs” (extracellular vesicles) restricting the activation of inflammatory cytokines in the brain of mice. More

  • Building Tiny Biocompatible Batteries with Heart-Defibrillating Power

    Dec 04 | Bio-IT World | In a paper published last week in Science, researchers from the University of Oxford, UK, demonstrate how microprocessors can be created from soft, biocompatible, nanoliter-scale hydrogel droplets. This work builds on a study published last month in Nature Chemical Engineering introducing poppyseed-sized droplet batteries that can be used to power such systems for various bionic and biomedical applications. More

  • Barcelona Research Institutions Launch Joint Program on Evolutionary Medical Genomics

    Dec 03 | Bio-IT World | Three research institutions in Barcelona have teamed up to launch the world’s first Joint Program on Evolutionary Medical Genomics. The initiative, launched last month at an inaugural symposium in Barcelona Biomedical Research Park (PRBB), is a collaboration between the Centre for Genomic Regulation (CRG), the Department of Medicine and Life Sciences at the Universitat Pompeu Fabra (UPF), and the Institut de Biologia Evolutiva More

  • Follow the Money: Seaport Therapeutics Glyph Platform, Pathos AI Expansion, More

    Nov 26 | Bio-IT World | Seaport nets funds for its Glyph technology platform; Pathos AI plans to accelerate its AI-powered drug development platform; Alentis Therapeutics pursues antibody drug conjugates; and more. More

  • Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

    Nov 25 | Bio-IT World | Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based induced pluripotent stem cell and bio data repository; Scale Biosciences and Revvity’s business, BioLegend, announced the availability of a first-of-its-kind TotalSeq Phenocyte single-cell protein profiling solution that supports customers by more easily identifying and characterizing rare cell subtypes; ChapsVision has acquired Sinequa; and more. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!